Stellate Ganglion Block to Treat Long COVID 19 Case Series

Completed

Conditions studied: Long COVID, Long Covid19, Post-COVID-19 Syndrome, Post Acute COVID-19 Syndrome, Dysautonomia, Anosmia, Dysgeusia, Brain Fog, Muscle Pain, Shortness of Breath, Dizziness, Fatigue Post Viral, Cough, Menstrual Cycle Abnormal, Pain

In brief

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Key facts

Study ID

NCT05812209

Run by

Metamorphosis LTD

People needed

41

Starts

2022-09-01

Expected to finish

2022-12-31

Last updated by the study team

2023-04-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Stellate Ganglion Block Contraindications

Where it is running

• Metamorphosis LTD — Cañon City, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.